Very late stent thrombosis associated with COVID-19 infection: a case report and review of the literature

• Published in: Monaldi archives for chest disease Vol. 92; no. 2
• Main Authors: Kunal, Shekhar, Pathak, Vijay, Pathak, Keshav, Mishra, Monika, Sharma, Shashi Mohan, Bhandari, Sudhir
• Format: Journal Article
• Language: English
• Published: Italy PAGEPress Publications 16-09-2021
• Subjects: Acute coronary syndrome; Adult; coronavirus; COVID-19; COVID-19 - complications; COVID-19 Testing; Drug-Eluting Stents - adverse effects; Humans; Male; Platelet Aggregation Inhibitors; pneumonia; SARS-CoV-2; stent thrombosis; Stents - adverse effects; Thrombosis - diagnostic imaging; Thrombosis - etiology
• ISSN: 1122-0643; 2532-5264
• DOI: 10.4081/monaldi.2021.1802

Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 has varied manifestation with multisystem involvement. Acute coronary syndrome in COVID-19 as a result of stent thrombosis is an uncommon entity and is often due to hypercoagulable state. A 40-year-old male was referred to us with acute onset chest pain. He also reported fever, sore throat and dry cough for six days which mandated testing for COVID-19 which turned out to be positive. He had a prior history of coronary artery disease with a drug eluting stent implanted two years back. An electrocardiogram was suggestive of acute anterior wall myocardial infarction while echocardiogram revealed hypokinesia of left anterior descending (LAD) artery territory. Coronary angiogram revealed non-occlusive thrombus in proximal LAD stent. A Thrombolysis in Myocardial Infarction (TIMI) III flow was restored following balloon angioplasty with a non-compliant balloon and use of glycoprotein (GP) IIb-IIIa receptor antagonist. A diagnosis of very late stent thrombosis subsequent to COVID-19 was made.